These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 15826665)
1. A structure-based database of antibody variable domain diversity. Bond CJ; Wiesmann C; Marsters JC; Sidhu SS J Mol Biol; 2005 May; 348(3):699-709. PubMed ID: 15826665 [TBL] [Abstract][Full Text] [Related]
2. Phage-displayed antibody libraries of synthetic heavy chain complementarity determining regions. Sidhu SS; Li B; Chen Y; Fellouse FA; Eigenbrot C; Fuh G J Mol Biol; 2004 Apr; 338(2):299-310. PubMed ID: 15066433 [TBL] [Abstract][Full Text] [Related]
3. Energy-based analysis and prediction of the orientation between light- and heavy-chain antibody variable domains. Narayanan A; Sellers BD; Jacobson MP J Mol Biol; 2009 May; 388(5):941-53. PubMed ID: 19324053 [TBL] [Abstract][Full Text] [Related]
4. Analysis of the horse V(H) repertoire and comparison with the human IGHV germline genes, and sheep, cattle and pig V(H) sequences. Almagro JC; Martinez L; Smith SL; Alagon A; Estevez J; Paniagua J Mol Immunol; 2006 Apr; 43(11):1836-45. PubMed ID: 16337682 [TBL] [Abstract][Full Text] [Related]
5. Structure of a non-camelized human M12-V(H) domain at 1.5A resolution. Gaur RK J Struct Biol; 2005 Oct; 152(1):84-9. PubMed ID: 16183303 [TBL] [Abstract][Full Text] [Related]
6. Length of the antibody heavy chain complementarity determining region 3 as a specificity-determining factor. Barrios Y; Jirholt P; Ohlin M J Mol Recognit; 2004; 17(4):332-8. PubMed ID: 15227640 [TBL] [Abstract][Full Text] [Related]
7. Display of somatostatin-related peptides in the complementarity determining regions of an antibody light chain. Simon PJ; Brogle KC; Wang B; Kyle DJ; Soltis DA Arch Biochem Biophys; 2005 Aug; 440(2):148-57. PubMed ID: 16051181 [TBL] [Abstract][Full Text] [Related]
9. The human combinatorial antibody library HuCAL GOLD combines diversification of all six CDRs according to the natural immune system with a novel display method for efficient selection of high-affinity antibodies. Rothe C; Urlinger S; Löhning C; Prassler J; Stark Y; Jäger U; Hubner B; Bardroff M; Pradel I; Boss M; Bittlingmaier R; Bataa T; Frisch C; Brocks B; Honegger A; Urban M J Mol Biol; 2008 Feb; 376(4):1182-200. PubMed ID: 18191144 [TBL] [Abstract][Full Text] [Related]
10. Crystal structure of a shark single-domain antibody V region in complex with lysozyme. Stanfield RL; Dooley H; Flajnik MF; Wilson IA Science; 2004 Sep; 305(5691):1770-3. PubMed ID: 15319492 [TBL] [Abstract][Full Text] [Related]
11. Human immunoglobulin repertoires against tetanus toxoid contain a large and diverse fraction of high-affinity promiscuous V(H) genes. de Kruif J; Kramer A; Visser T; Clements C; Nijhuis R; Cox F; van der Zande V; Smit R; Pinto D; Throsby M; Logtenberg T J Mol Biol; 2009 Apr; 387(3):548-58. PubMed ID: 19361421 [TBL] [Abstract][Full Text] [Related]
12. Crystal structure of a human VH: requirements for maintaining a monomeric fragment. Dottorini T; Vaughan CK; Walsh MA; LoSurdo P; Sollazzo M Biochemistry; 2004 Jan; 43(3):622-8. PubMed ID: 14730966 [TBL] [Abstract][Full Text] [Related]
13. Design and validation of a synthetic VH repertoire with tailored diversity for protein recognition. Almagro JC; Quintero-Hernández V; Ortiz-León M; Velandia A; Smith SL; Becerril B J Mol Recognit; 2006; 19(5):413-22. PubMed ID: 16881059 [TBL] [Abstract][Full Text] [Related]
14. Crystal structure of HEL4, a soluble, refoldable human V(H) single domain with a germ-line scaffold. Jespers L; Schon O; James LC; Veprintsev D; Winter G J Mol Biol; 2004 Apr; 337(4):893-903. PubMed ID: 15033359 [TBL] [Abstract][Full Text] [Related]
15. Aggregation-resistant VHs selected by in vitro evolution tend to have disulfide-bonded loops and acidic isoelectric points. Arbabi-Ghahroudi M; To R; Gaudette N; Hirama T; Ding W; MacKenzie R; Tanha J Protein Eng Des Sel; 2009 Feb; 22(2):59-66. PubMed ID: 19033278 [TBL] [Abstract][Full Text] [Related]
16. Contributions of CDR3 to V H H domain stability and the design of monobody scaffolds for naive antibody libraries. Bond CJ; Marsters JC; Sidhu SS J Mol Biol; 2003 Sep; 332(3):643-55. PubMed ID: 12963373 [TBL] [Abstract][Full Text] [Related]
17. The importance of framework residues H6, H7 and H10 in antibody heavy chains: experimental evidence for a new structural subclassification of antibody V(H) domains. Jung S; Spinelli S; Schimmele B; Honegger A; Pugliese L; Cambillau C; Plückthun A J Mol Biol; 2001 Jun; 309(3):701-16. PubMed ID: 11397090 [TBL] [Abstract][Full Text] [Related]
18. Enhanced conformational diversity search of CDR-H3 in antibodies: role of the first CDR-H3 residue. Kim ST; Shirai H; Nakajima N; Higo J; Nakamura H Proteins; 1999 Dec; 37(4):683-96. PubMed ID: 10651282 [TBL] [Abstract][Full Text] [Related]
19. Simulated mutagenesis of the hypervariable loops of a llama VHH domain for the recovery of canonical conformations. Velez-Vega C; Fenwick MK; Escobedo FA J Phys Chem B; 2009 Feb; 113(6):1785-95. PubMed ID: 19132876 [TBL] [Abstract][Full Text] [Related]
20. High-affinity human antibodies from phage-displayed synthetic Fab libraries with a single framework scaffold. Lee CV; Liang WC; Dennis MS; Eigenbrot C; Sidhu SS; Fuh G J Mol Biol; 2004 Jul; 340(5):1073-93. PubMed ID: 15236968 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]